Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 8 Issue 2

Simultaneous Analysis of Anti-Hypertensive Drugs by RP-HPLC: An Overview

Akshay Katkale1*, Sagar Fodase1, Sanket Joshi2 and Shubham Babare2

1Department of Pharmaceutical Chemistry, MVP Samaj’s College of Pharmacy, Nashik, Maharashtra, India
2Department of Quality Assurance Technique, Sanjivani College of Pharmaceutical Education and Research, Sahajanand Nagar, Shingnapur, Kopargaon, Maharashtra, India

*Corresponding Author: Akshay Katkale, Department of Pharmaceutical Chemistry, MVP Samaj’s College of Pharmacy, Nashik, Maharashtra, India.

Received: January 05, 2024; Published: January 22, 2024

Abstract

High performance liquid chromatography (HPLC) is an important qualitative and quantitative technique, generally used for the estimation of pharmaceutical and biological samples. In now a day pharmaceutical market, many newer antihypertensive combination drugs are available to control hypertension as well as to keep society healthy and stress free. All presently available old drugs have frequent dosing produces various side effects. So, there is need to analyse such antihypertensive drugs. The aim of this review is to analysed such commonly used antihypertensive combination drugs by using reverse phase high performance liquid chromatography (RP-HPLC). Reversed-phase high-performance liquid chromatography (RP-HPLC) involves the separation of molecules on the basis of hydrophobicity. The separation depends on the hydrophobic binding of the solute molecule from the mobile phase to the immobilized hydrophobic ligands attached to the stationary phase. The drugs like Amlodipine besylate and Valsartan, Irbesartan and Hydrochlorothiazide, Atenolol and Chlorthalidone, Hydrochlorothiazide and Candesartan, Ramipril and Amlodipine, Hydrochlorothiazide and Enalapril, Quinapril and Hydrochlorothiazide etc. About fifteen combination drugs are analysed by using RP-HPLC. This review assists in appropriate selection of column, mobile phase, pH, flow rate, detector and form of such combination drugs.

Keywords: Simultaneous Analysis; Antihypertensive; Combination; RP-HPLC

References

  1. Martin M and Guiochon G. “Effects of high pressures in liquid chromatography”. Journal of Chromatography A 1-2.7 (2005): 16-38.
  2. Liu Y and Lee ML. “Ultrahigh pressure liquid chromatography using elevated temperature”. Journal of Chromatography 1-2 (2006): 198-202.
  3. Abidi SL. “High-performance liquid chromatography of phosphatidic acids and related polar lipids”. Journal of Chromatography 587 (1991): 193-203.
  4. Hearn MT. “Ion-pair chromatography on normal and reversed-phase systems”. Advances in Chromatograpy 18 (1980): 59-100.
  5. Tripathi KD. “Essentials of medical pharmacology. Sixth edition, Jaypee Brothers Medical Publishers (P) Ltd. New Delhi, (2003): 539-540.
  6. WHO Hypertension.
  7. Combination drug.
  8. Rahul RN., et al. “Stability indicating RP-HPLC method for simultaneous determination of amlodipine besylate and combination in bulk and commercial dosage form”. Asian Journal of Biological and Life Sciences 2 (2012): 280-290.
  9. Dyade GK and Sawank RL. “Validated RP-HPLC method and unique mobile phase for the simultaneous estimation of amlodipine besylate and valsartan from solid dosage form bulk and rosuvastatin and valsartan”. Asian Journal of Research in Chemistry6 (2018): 31-36.
  10. Patel BS., et al. “Stability indicating RP-HPLC method for simultaneous determination of valsartan and amlodipine from their Combination dosage form”. International Journal of ChemTech Research4 (2019): 1257-1267.
  11. Ali TA., et al. “RP-HPLC stability indicating method for estimation irbesartan and hydrochlorothiazide in bulk and pharmaceutical dosage form”. Chinese Journal of Analytical Chemistry1 (2016): 1601-1608.
  12. Esward M., et al. “RP-HPLC method development and validation for simultaneous estimation of irbesartan and hydrochlorothiazide in pharmaceutical dosage form”. Asian Journal of Research in Chemistry4 (2012): 348-352.
  13. Ravishankar P., et al. “Novel RP-HPLC method for simultaneous determination of irbesartan and hydrochlorothiazide in bulk and tablet dosage form”. Science Spectrum3 (2016): 309-330.
  14. Kumar GS., et al. “Development and validation of RP-HPLC method for simultaneous estimation of atenolol and chlorthalidone from pharmaceutical formulation”. International Research Journal of Pharmacy10 (2012): 215-218.
  15. Devi AL., et al. “A New RP-HPLC method development and validation for the dissolution studies of atenelol and chlorthalidone immediate Release Tablet dosage form”. International Journal Of Research in Pharmacy and Chemistry4 (2014): 958-965.
  16. Devi RG and Nagarajun K. “Analytical method development and validation for the estimation of chlorthalidone and atenolol by RP-HPLC”. International Journal of Academic Research and Development 10 (2018): 133:137.
  17. Bonthu MG., et al. “Simultaneous determination of candesartan and hydrochlorothiazide in human plasma by LC-MS/MS”. Brazilian Journal of Pharmaceutical Sciences1 (2018): e17381.
  18. Madhavi K., et al. “Simple analytical method for the simtameous estimation hydrochlorthazide and condesartan by RP-HPLC”. International Journal of Applied Pharma6 (2017): 35-37.
  19. Shrikalyani V., et al. “Simultaneous estimation of hydrochlorothiazide and condesartan in bulk and pharmaceutical dosage form by RP-HPLC PDA method”. International Journal of Pharmaceutical Sciences and Research1 (2018): 150-157.
  20. Kotthiredddy K., et al. “Stability indicating RP-HPLC method development and validation for the simultaneous estimation of condesartan cilexeotil and hydrochlorothiazide in bulk and tablet dosage form”. Scholar’s Research Library12 (2015): 114-121.
  21. Dai SY., et al. “Development and validation of an RP-HPLC method for simultaneous determination of ramipril and amlodipine in tablets”. Journal of Pharmaceutical Analysis6 (2013): 440-446.
  22. Anand BK., et al. “Simultaneous estimation of ramipril and amlodipine in pharmaceutical dosage form by RP-HPLC method”. International Journal of Pharmacy and Pharmaceutical Sciences4 (2014): 196-198.
  23. Rajput PS., et al. “Simultaneous estimation of ramipril and amlodipine in bulk and tablet dosage form by RP-HPLC method”. Journal of Applied Pharmaceutical Sciences7 (2012): 160-165.
  24. Hammouda M., et al. “Simultaneous Determination of enalapril and hydrochlorothiazide in Pharmaceutical Preparations Using Microemulsion Liquid Chromatography”. Journal of Chromatography 53 (2015): 90-96.
  25. Surydevara V., et al. “Analytical method development and validation for simultaneous estimation of enalapril maleate and hydrochlorothiazide by RP-HPLC”. Der Pharma Chemica1 (2014): 217-223.
  26. Foda NH., et al. “Simultaneous HPLC determination of Enalapril and Hydrochlorothiazide in human plasma and its pharmacokinetics application”. Journal of Pharmaceutical Sciences and Research11 (2012): 786-794.
  27. Keerthi J and Subramaniyan D. “Analytical method development and validation for the simultaneous estimation of enalapril and hydrochlorothiazide by RP-HPLC method in bulk and pharmaceutical dosage form”. Journal of Pharmaceutical Analysis 12 (2019): 323-332.
  28. Prameela KL., et al. “Stability indicating reverse phase high performance liquid chromatographic method with photodiode array detection for the simultaneous quantification of quinapril and hydrochlorthiazide in bulk and tablet dosage forms”. Asian Journal of Chemistry4 (2018): 873-878.
  29. Rani GS., et al. “A new RP-HPLC method for simultaneous estimation of quinapril and hydrochlorothiazide in pharmaceutical dosage form”. World Journal of Pharmacy and Pharmaceutical Sciences6 (2013): 6220-6234.
  30. Altunsoy S and Bonzal B. “Validation of liquid chromatography method for simultaneous determination of quinapril and hydrochlorothiazide in pharmaceutical dosage form”. Turkish Journal Of Pharmaceutical Sciences 2 (2013): 255-262.
  31. Megala K., et al. “Validated RP-HPLC method for simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical formulation”. International Journal of Pharmaceutical Research and Allied Sciences 3 (2014): 33-40.
  32. Wankhede SB., et al. “RP-HPLC method for simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form”. Indian Journal of Pharmaceutical Sciences2 (2007): 298-300.
  33. Mukhopodhyay S., et al. “Simultaneous determination of related substances of telmisartan and hydrochlorothiazide in tablet dosage form by using RP-HPLC method”. Indian Journal of Pharmaceutical Sciences3 (2012): 375-383.
  34. Aher SS., et al. “Devlopement and validation of RP-HPLC method for simultaneous estimation of azilsartan medoxomil and chlorthalidone in bulk and tablet dosage form”. International Journal of Current Pharmaceutical Research 6 (2018): 22-23.
  35. Naazneen S and Sridevi A. “Stability indicating RP-HPLC method for the simultaneous estimation of azilsartan medoxomil and chlorthalidone in solid dosage form”. International Journal of Pharmacy and Pharmaceutical Sciences 6 (2014): 237-242.
  36. Sohani SK., et al. “Development and validation of RP-HPLC method for simultaneous estimation of azilsartan and chlorthalidone in bulk form and formulation using quality by design”. International Journal of Pharmacy and Pharmaceutical Sciences2 (2016): 267-271.
  37. Huang T., et al. “Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution”. Journal of Pharmaceutical and Biomedical Analysis 41 (2006): 644-648.
  38. Veerubhotia K and Walker RB. “Development and validation of stability indicating RP-HPLC method using quality by design for estimation captopril”. Indian Journal of Pharmaceutical Sciences1 (2019): 45-56.
  39. Ivanovic D., et al. “Validation of the RP-HPLC method for analysis of hydrochlorothiazide and captopril in tablet”. Accreditation and Quality Assurance 9 (2004): 76-81.
  40. Hossen A., et al. “Development and validation of RP-HPLC method for the simultaneous estimation of hydrochlorothiazide and losartan potassium in tablet dosage form”. Dhaka University Journal of Pharmaceutical Sciences1 (2011): 35-42.
  41. Argekar AP and Sawant JG. “A gradient reversed phase HPLC method for simultaneous determination of hydrochlorothiazide and losartan potassium”. Analytical Later5 (2008): 869-880.
  42. Sibel A Ozkan. “Simultaneous determination of losartan potassium and hydrochlorothiazide from tablet and human serum by RP-HPLC”. Journal of Liquid Chromatography and Related Technologies15 (2007): 2337-2346.
  43. Naikini P., et al. “RP-HPLC method development and validation for the simultaneous estimation of amlodipine and atenolol in bulk and tablet dosage form”. International Journal of Pharmacy and Pharmaceutical Sciences 1 (2014): 391-393.
  44. Phillip B., et al. “RP-HPLC development and validation for simultaneous estimation of atenelol and amlodipine besylate in pharmaceutical dosage form”. Journal of Pharmaceutical Sciences and Research1 (2010): 345-355.
  45. Haque A and Nazin A. “Development and validation of RP-HPLC method for the simultaneous estimation of atenolol and amlodipine in tablet dosage form”. Dhaka University Journal of Pharmaceutical Sciences2 (2010): 131-138.
  46. Ganipisetty LA., et al. “Stability indicating RP-HPLC method development and validation of simultaneous estimation.n of trandolapril and verapamil hydrochloride with forced degradation studies in bulk and commercial products”. IJPRS4 (2015): 1-8.
  47. Srilatha Saikiran G., et al. “Reverse phase high performance liquid chromatography method development and validation for the simultaneous determination of verapamil and trandolapril in pure form and their marketed combined pharmaceutical dosage form”. International Journal of Farmacia4 (2020): 236-256.
  48. Laxmi PM and Geotha V. “Devlopment and validation of RP-HPLC method for the simultaneous estimation of verapamil hydrochloride and trandolapril in bulk and pharmaceutical dosage form”. Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry1 (2016): 38-46.
  49. Hema P., et al. “Chemometric assisted RP-HPLC quantitative estimation and validation of hydrochlorothiazide and triamterene in tablet dosage form”. International Journal of Pharmacy and Analytical Research 3 (2017): 442-448.
  50. Sathyanaryana P., et al. “Analytical method development and validation of simultaneous estimation of hydrochlorothiazide and triamterene in combined tablet dosage form by RP HPLC”. International Research Journal of Pharmacy and Pharmacology1 (2018): 48-54.
  51. Margaryan T., et al. “Simultaneous determination of triamterene and hydrochlorothiazide in human plasma by liquid chromatography tandem mass spectrometry and its application to a bioequivalence study”. S N Applied Sciences 1 (2019): 653.
  52. Neelima K and Rajendra Y. “Analytical method development and validation for simultaneous estimation of hydralazine, isosorbide dinitrate in bulk and tablet formulation by RP-HPLC”. Indian Journal of Pharmaceutical Sciences 4 (2014): 1290-1294.
  53. Patel VS and Pandya SS. “A review on analytical methods for estimation of isosorbride dinitrate and hydralazine hydrochloride in bulk and pharmaceutical dosage form”. International Journal of ChemTech Research 10 (2017): 92-94.
  54. Mastanamma SK., et al. “Stability indicating validated RP-HPLC method for simultaneous determination of hydralazine hydrochloride and isosorbide denigrate in bulk and pharmaceutical dosage form”. International Journal of Pharmaceutical Sciences 1 (2016): 141-148.

Citation

Citation: Akshay Katkale., et al. “Simultaneous Analysis of Anti-Hypertensive Drugs by RP-HPLC: An Overview".Acta Scientific Pharmaceutical Sciences 8.2 (2024): 43-57.

Copyright

Copyright: © 2024 Akshay Katkale., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US